Abstract

Clitorea ternatea has been used in Ayurvedic medicine as a brain stimulant to treat mental illnesses and mental functional disorders. In this study, the metabolite profiles of crude C. ternatea root extract (CTRE), ethyl acetate (EA), and 50% aqueous methanol (50% MeOH) fractions were investigated using ultrahigh-performance liquid chromatography–diode array detector–tandem mass spectrometry (UHPLC–DAD–MS/MS), while their effect on the stress-like behavior of zebrafish, pharmacologically induced with reserpine, was investigated. A total of 32 compounds were putatively identified, among which, a series of norneolignans, clitorienolactones, and various flavonoids (flavone, flavonol, isoflavone, and isoflavanone) was found to comprise the major constituents, particularly in the EA and 50% MeOH fractions. The clitorienolactones, presently unique to the species, were present in both the free and glycosylated forms in the roots. Both the EA and 50% MeOH fractions displayed moderate effects on the stress-induced zebrafish model, significantly decreasing freezing duration and elevating the total distance travelled and average velocity, 72 h post-treatment. The results of the present study provide further evidence that the basis for the use of C. ternatea roots in traditional medicine to alleviate brain-related conditions, such as stress and depression, is attributable to the presence of clitorienolactones and the isoflavonoidal constituents.

Highlights

  • Recent statistics released by the World Health Organization (WHO) have revealed that more than 264 people globally have been diagnosed with some form of mental disorder, including depression [1]

  • Peak assignments and the metabolites putatively identified in C. ternatea root extract based on the LC–MS/MS data obtained in the negative mode (ESI− ) are displayed in Figure 1 and Table 1, respectively

  • The ethyl acetate (EA) fraction was found to be richer in the flavonoidal constituents, while the 50%

Read more

Summary

Introduction

Recent statistics released by the World Health Organization (WHO) have revealed that more than 264 people globally have been diagnosed with some form of mental disorder, including depression [1]. People suffering from depression experience varying clinical symptoms, such as loss of bodyweight, sleep disturbances, and feelings of indecisiveness, guilt, and irritability, as well as intense fatigue [2,3]. Left untreated, such conditions have been reported to worsen, even leading to suicidal thoughts.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call